Trident Texofab23.33
+0.64 (+2.82%)

Trident Texofab Share Price

23.33+0.64 (+2.82%)
-90.45% past 1 Year

Trident Texofab Limited is a prominent semi-composite textile manufacturing and trading Company that delivers a wide range of products, including home furnishing, garments, suiting, shirting, technical textiles, and fabrics. In

Corporate filings & documents

Announcements

The Company voluntarily requested withdrawal of its credit ratings from CRISIL Ratings Limited for the bank facilities availed from Axis Bank Limited as the sanctioned credit limits are below the Banks requirement for maintaining an external credit rating. CRISIL Ratings Limited vide its letter dated September 01 2026 confirmed the withdrawal of the credit ratings assigned to the Companys bank facilities. The withdrawal was effected upon receipt of the No Objection Certificate from Axis Bank Limited in line with CRISILs policy on credit rating withdrawal.
2 days ago
The Company voluntarily requested withdrawal of its credit ratings from CRISIL Ratings Limited for the bank facilities availed from Axis Bank Limited as the sanctioned credit limits are below the Banks requirement for maintaining an external credit rating. CRISIL Ratings Limited vide its letter dated September 01 2026 confirmed the withdrawal of the credit ratings assigned to the Companys bank facilities. The withdrawal was effected upon receipt of the No Objection Certificate from Axis Bank Limited in line with CRISILs policy on credit rating withdrawal.
2 days ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust
1 week ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust
1 week ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust
1 week ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust
1 week ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust
2 weeks ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust
2 weeks ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust
2 weeks ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hardik Desai Family Trust
2 weeks ago
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations we hereby enclose copies of newspaper advertisement published on 12th August 2026 regarding extract of the Un-Audited Standalone Financial Results for the quarter ended June 30 2026
3 weeks ago
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations we hereby enclose copies of newspaper advertisement published on 12th August 2026 regarding extract of the Un-Audited Standalone Financial Results for the quarter ended June 30 2026
3 weeks ago
The Board took on record Resignation of M/s. Shah Kailash and Associates LLP Chartered Accountant FRN: 109647W as Statutory Auditor of the Company with effect from 10th August 2026
3 weeks ago
The Board took on record Resignation of M/s. Shah Kailash and Associates LLP Chartered Accountant FRN: 109647W as Statutory Auditor of the Company with effect from 10th August 2026
3 weeks ago
The Board of Directors inter-alia has approved the Appointment of M/s. Prit Agrawal & CO. Chartered Accountant having FRN No. 152249W as an Internal Auditor for the financial year 2026-27.
3 weeks ago
The Board of Directors inter-alia has approved the Appointment of M/s. Prit Agrawal & CO. Chartered Accountant having FRN No. 152249W as an Internal Auditor for the financial year 2026-27.
3 weeks ago
Un-Audited Financial Results for the quarter ended on June 30 2026 along with Limited Review Report on said results by the Statutory Auditor of the Company
3 weeks ago
Un-Audited Financial Results for the quarter ended on June 30 2026 along with Limited Review Report on said results by the Statutory Auditor of the Company
3 weeks ago
Outcome of Board Meeting held on 10.08.2026
3 weeks ago
Outcome of Board Meeting held on 10.08.2026
3 weeks ago
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve un-audited standalone financial results for the quarter ended June 30 2026.
1 month ago
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve un-audited standalone financial results for the quarter ended June 30 2026.
1 month ago
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 as received from KFin Technologies Limited- Companys Registrar and Share Transfer Agent for the quarter ended June 30 2026.
1 month ago
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 as received from KFin Technologies Limited- Companys Registrar and Share Transfer Agent for the quarter ended June 30 2026.
1 month ago
Please find the attached Credit rating assigned by CRISIL Rating.
1 month ago
Please find the attached Credit rating assigned by CRISIL Rating.
1 month ago
Please find the attachment for Intimation of Forfeiture of Upfront Consideration and Lapse of Warrants
2 months ago
Please find the attachment for Intimation of Forfeiture of Upfront Consideration and Lapse of Warrants
2 months ago
Outcome of Board Meeting held on 02.07.2026
2 months ago
Outcome of Board Meeting held on 02.07.2026
2 months ago
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from July 01 2026 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Un-Audited Standalone Financial Results for the Quarter ended June 30 2026.
2 months ago
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from July 01 2026 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Un-Audited Standalone Financial Results for the Quarter ended June 30 2026.
2 months ago
In compliance with the Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with relevant Circular(s) issued by SEBI in this regard please find enclosed herewith the Annual Secretarial Compliance Report for Financial Year ended March 31 2026 issued by Amareliya & Associates Practising Company Secretary.
3 months ago
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations we hereby enclose copies of newspaper advertisement published regarding extract of the Audited Financial Results for the quarter and Year ended March 31 2026.
3 months ago
Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations we hereby enclose copies of newspaper advertisement published regarding extract of the Audited Financial Results for the quarter and Year ended March 31 2026.
3 months ago
Financial Result for Quarter and Year ended 31.03.2026
3 months ago
Financial Result for Quarter and Year ended 31.03.2026
3 months ago
Outcome of Board Meeting held on 30.05.2026
3 months ago
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Financial Result which it to be held on 28.05.2026. Due to Delay in Preparation of Financial Accout now Board Meeting to be Adjourned to 30.05.2026
3 months ago
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve financial result for the Quarter and year ended 31.03.2026
3 months ago
Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 inter alia to consider and approve financial result for the Quarter and year ended 31.03.2026
3 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Trident Texofab Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L17120GJ2008PLC054976</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>20.21</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>B+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CRISIL LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: RAHUL JARIWALA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: JENISH B JARIWALA <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Trident Texofab Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L17120GJ2008PLC054976</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>20.21</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>B+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>CRISIL LTD.</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: RAHUL JARIWALA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: JENISH B JARIWALA <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago
This is with reference to your email dated 15th April 2026 and Letter No. L/SURV/ONL/PV/APJ/ 2026-2027 / 3730 received from BSE seeking clarification regarding the significant movement in price of the share price of the company. In this regards we wish to inform you that all the material information/announcement that may have bearing on the operations/performance of the Company which includes all the necessary disclosures in accordance with regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and under insider trading regulation have always been disclosed by the Company within the stipulated time. There is no pending information or announcement which have a bearing on price movement of the Company. Therefore The movement in Companys share price is purely due to market conditions and are market driven on which the Company neither has any control nor has any knowledge of reasons.
4 months ago
This is with reference to your email dated 15th April 2026 and Letter No. L/SURV/ONL/PV/APJ/ 2026-2027 / 3730 received from BSE seeking clarification regarding the significant movement in price of the share price of the company. In this regards we wish to inform you that all the material information/announcement that may have bearing on the operations/performance of the Company which includes all the necessary disclosures in accordance with regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and under insider trading regulation have always been disclosed by the Company within the stipulated time. There is no pending information or announcement which have a bearing on price movement of the Company. Therefore The movement in Companys share price is purely due to market conditions and are market driven on which the Company neither has any control nor has any knowledge of reasons.
4 months ago
The Exchange has sought clarification from Trident Texofab Ltd on April 15 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
4 months ago
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 as received from KFin Technologies Limited- Companys Registrar and Share Transfer Agent for the quarter ended March 31 2026.
4 months ago
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from April 01 2026 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Audited Standalone Financial Results for the Quarter and year ended March 31 2026.
5 months ago
We wish to inform you that pursuant to Schedule IV of the Companies Act 2013 and Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 a Separate Meeting of the independent Directors was held on today i.e. March 27 2026
5 months ago
We wish to inform you that pursuant to Schedule IV of the Companies Act 2013 and Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 a Separate Meeting of the independent Directors was held on today i.e. March 27 2026
5 months ago

Concalls & investor presentations

Feb 2026
Aug 2025
May 2025
Feb 2025
Oct 2024
Jul 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
Apr 2023
Jan 2023
Oct 2022
Jul 2022
Apr 2022
Jan 2022
Oct 2021
Aug 2021
Jun 2021
Feb 2021
Feb 2021
Nov 2020

Corporate Actions

Date
Type
Details
No data available.

Company details

Registered office

2004, 2nd Floor, North Extension Falsawadi Ring Road Surat Gujarat PIN: 395003 Tel No: 0261-2451284 / 74 Fax No: NULL Email: [email protected] / [email protected] Internet: www.tridenttexofab.com

Registrars

Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com

Management

Rahul Jariwala, Company Secretary & Compliance Officer

Hardik Jigishkumar Desai, Chairman & Managing Director

Hardik Jigishkumar Desai, Chairman & Managing Director

Chetan C Jariwala, Whole Time Director

Ankita Jignesh Saraiya, Non Executive Independent Director

Manish Dhirajlal Halwawala, Executive Director

Mishal Shailesh Patel, Non Executive Independent Director

Sandip Jayeshkumar Katwala, Non Executive Independent Director

Details

BSE 540726

NSE NULL

ISIN INE071Y01013

Trident Texofab Ltd Share Price Today

The Trident Texofab Ltd share price today is ₹22.98. During the trading session, the Trident Texofab Ltd share price opened at ₹22.85 and recorded an intraday high of ₹23.45 and a low of ₹22.55. Last closing price was ₹22.74. Over the past 52 weeks, the Trident Texofab Ltd share price has ranged between ₹21.30 and ₹379.00. The current Trident Texofab Ltd stock price reflects real-time market activity based on executed trades on the exchange.